Bionano Genomics, Inc.
BNGO
$1.14
-$0.03-2.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.93M | -8.50M | -6.86M | -3.10M | -20.13M |
| Total Depreciation and Amortization | 2.39M | 2.43M | 2.43M | 2.49M | 2.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.11M | 1.17M | 1.70M | -4.17M | 9.15M |
| Change in Net Operating Assets | 264.00K | -1.01M | -763.00K | 2.02M | 2.03M |
| Cash from Operations | -4.18M | -5.92M | -3.49M | -2.76M | -6.50M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.01M | -4.67M | 1.98M | -14.07M | 3.00M |
| Cash from Investing | 4.01M | -4.67M | 1.98M | -14.07M | 3.00M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -18.00K | -1.89M | -1.52M | -1.52M | -2.01M |
| Issuance of Common Stock | 1.75M | 12.94M | 3.09M | 13.33M | 6.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -130.00K | -969.00K | -104.00K | -919.00K | -818.00K |
| Cash from Financing | 1.60M | 10.08M | 1.47M | 10.89M | 3.89M |
| Foreign Exchange rate Adjustments | 7.00K | 15.00K | -24.00K | -9.00K | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.44M | -497.00K | -63.00K | -5.95M | 379.00K |